Learning Objectives: Participants should be able to: after completing this program.

Describe the impact of drugs, alcohol, and tobacco on people who are tolerant and those who are not.
Exhibit a practical understanding of the neuroscience of addiction and explain its functioning in terms that are relevant to a clinical context.
Describe the method used to diagnose addiction and distinguish its symptoms from those of other mental or physical illnesses.
Describe the many psychosocial and pharmacologic treatments available for addictive disorders, as well as the factors to be taken into account when choosing a treatment plan that best suits the needs of a certain patient.
Explain the factors that lead to relapse and the evidence-based strategies used today to manage and prevent recurrence.
Course: Fundamentals of Addiction
Review of Addictive Disorders and Substance Use in the DSM-5 (0.5 Hours)
Dr. Antoine Douaihy
Concepts and Trends in Epidemiology I–II (1.5 Hours)
Christopher Holden, M.D.
Addiction’s Genetic Basis (0.5 Hours)
Marcela Smid, Ph.D.
Addiction’s Neurobiology (0.5 Hours)
Dr. Maher Karam-Hage
Screening, Evaluation, and I-II Brief Interventions (One Hour)
Dr. Antoine Douaihy
Clinical and Legal Aspects of Drug Testing (0.75 Hours)
Overview of Addiction Treatment (Concepts, Settings, Health Services) by R. Gregory Cochran, MD, PhD One hour
Christopher Holden, M.D.
Co-morbidities in psychiatry I–IV (2 Hours)
Pharmaceutical Co-Morbidities I–II by Ihsan M. Salloum, MD, MPH (1 Hour)
Dr. Alan Wartenberg
Principles I–II of pharmacotherapy: pharmacokinetic and pharmacodynamic (1 Hour)
Dr. Maher Karam-Hage
Interventions Psychosocial I–II: One Hour
Dr. Antoine Douaihy
Interventions Behavioral I–II: One Hour
Dr. Antoine Douaihy
Parts I–III of Motivational Interviewing: 1.5 hours
Dr. Maher Karam-Hage
Acute In- and Out-patient Management of Alcoholism and Withdrawal I–II (one hour)
Dr. Alan Wartenberg
Public health and prevention (0.75 hours)
Marcela Smid, Ph.D.
Evaluation of Alcohol-Related Disorders by Drug Class I–IV (two hours)
Ximena Sanchez-Medicine Samper
Disorders Associated with Opioids I–II (1 Hour)
Dr. Antoine Douaihy
Disorders Associated with Nicotine and Tobacco Use (0.5 Hours)
Dr. Maher Karam-Hage
Disorders Associated with Cannabis (0.5 Hours)
Sedatives/Hypnotic-Related Disorders Ihsan M. Salloum, MD, MPH I–II (one hour)
Ximena Sanchez-Medicine Samper
Disorders Associated with Caffeine: I–II (1 Hour)
Dr. Alan Wartenberg
Additional Drug Use Disorders (Designer Drugs, Steroids, etc.) I through III (1.5 hours)
Ximena Sanchez-Medicine Samper
Drug-Induced Psychiatric Conditions (Neurocognitive and Delirium Disorders) I–II (1 Hour)
Ihsan M. Salloum, MD, MPH Addictions to Gambling and Other Behaviors (1 Hour)
Jack Krasuski, M.D.
Particular Populations & Subjects: Handling Pain in Addict Patients I–IV (two hours)
Ximena Sanchez-Medicine Samper
Women’s Health and Pregnancy I–II (1 Hour)
Marcela Smid, Ph.D.
Children, Teens, and Young Adults I–V (Two and a Half Hour)
Ximena Sanchez-Medicine Samper
Senior Citizens I–II (1 Hour)
Dr. Alan Wartenberg
Workplace Addiction I–II (1 Hour)
Marcela Smid, Ph.D.
Populations that are Homeless and Incarcerated (0.5 Hours)
Marcela Smid, Ph.D.
LGBTQ Community, Ethnic and Cultural Groups (0.75 Hours)
Doctor and PhD R. Gregory Cochran
Addiction Practice I–II: Ethics and Professionalism (1 Hour)
R. Gregory Cochran, MD, PhD, Law I–II and Addiction Medicine
Doctor and PhD R. Gregory Cochran